Cytometry Part A is the official journal of the International Society for Advancement of
The scope of Cytometry Part A embraces all aspects of analytical cytology, which is
defined broadly as characterization and measurement of cells and cellular constituents for
biological, diagnostic, and therapeutic purposes. It includes components of cytochem-
istry, cytophysics, cell biology, molecular biology, nanotechnology, systems biology and
cytomics, physiology, pathology, histology, image analysis, statistics, instrumentation, high-
throughput and high-content analysis, clinical laboratory practice, and other relevant subjects.
Manuscripts may include new experimental results, descriptions of new methods
or modifications of existing ones, or new interpretations of previously published data.
Manuscripts from all countries are encouraged but must be in English. Authors are not
required to be members of the International Society for Advancement of Cytometry.
Review of Manuscripts
An expert and anonymous reviewing process is important in assessing the scientific
soundness of contributions to Cytometry Part A and frequently helps authors to present
their findings clearly and concisely.
The Editorial Board of Cytometry Part A selects reviewers, assists in review of
manuscripts, makes recommendations concerning the suitability of manuscripts for
publication, and advises the Editor-in-Chief on matters related to publication policy.
Authors are encouraged to include the names and addresses of persons outside their
own institutions who might be qualified to serve as reviewers. Authors can request
their manuscripts not be reviewed by reviewers whose opinions, they believe, may be
unfavorably biased. Authors may also request their manuscripts be transmitted to specific
members of the Editorial Board. Authors are now required to submit a brief statement
including the important contributions of the submitted paper and the reason(s) it should
be published in Cytometry Part A.
All manuscripts will be evaluated independently by two reviewers. Reviewers are
requested to submit written evaluations employing the following criteria:
1. Does the subject matter fall within the scope of Cytometry Part A?
2. Does the paper describe original findings and add significantly to knowledge in its field?
3. Are the aims, results, and discussion presented clearly and concisely?
4. Are the experimental methods generally acceptable and are they described in sufficient
detail to permit repetition of the work?
5. Is the documentation of the findings adequate?
6. Are the illustrations appropriate and of acceptable quality (high resolution images,
easily readable figures)?
7. Are quantitative results statistically supported?
8. Is the list of references current and complete?
9. Is Supplementary Material provided to further the understanding of results?
The Editor-in-Chief, on the basis of recommendations from the reviewers and the
Editorial Board, may accept the manuscript, decline it, return it for revision, or send it to a
third reviewer to referee differences of opinion between the initial reviewers.
Forms of Publication
Cytometry Part A publishes eight types of contributed papers.
Original Articles are full-length reports of original research in all fields of analytical
cytology. The investigation may contribute to the development, evaluation, or application of
cytometric methods and their use in biology and medicine. Manuscripts that use a biological
system to report on new technological developments without a novel biological statement
component may be reassigned by the editorial board as a Brief Report or Technical Note.
Rapid Publications are original articles of such timeliness and interest that they merit
priority processing. Authors must contact the Editor-in-Chief and/or Editorial Office by
email before submitting their paper explaining their reasons for requesting rapid
processing. If the Editor agrees with the request, the manuscript will be invited via
Manuscript Central and receive an expedited review and, when accepted, priority for
publication; otherwise the manuscript will be processed as a regular submission.
Brief Reports succinctly describe biological or similar observations that would be of
interest to the community but that do not contain enough information to warrant a full-
length article. Methods or approaches that contain limitations are also acceptable. They
should include a brief statement of purpose, an adequately detailed description of the
observation(s), a statement of expected results, and references to pertinent literature. The
Editor-in-Chief strongly supports the use of this manuscript format for reports on method
Technical Notes briefly describe improvements or helpful modifications in
procedures for cytometric and related techniques. The Technical Note should include a
brief statement of purpose, an adequately detailed description of the procedure, a
statement of expected results, and references to pertinent literature. Observations based
on the application of the method also may be included.
Commentaries are in general invited papers that are intended to highlight a high-
impact manuscript within the same issue of the journal. The size is limited to maximum
three printed pages.
Communications to the Editor provide a forum for communication of opinion,
interpretation, and new information on scientific/political matters. Letters are judged on
appropriateness of the subject and interest to the readers. They should be concise and to
the point, contain 1,500–2,000 words of text, 1-2 figures or tables and a maximum 12
references. All Communications to the Editor are peer reviewed.
Conference Reports are succinct compilations of conference events which can
include an overview of the proceedings, summaries of specific sessions or individual
presentations, or published abstracts.
Reviews are comprehensive appraisals of current cytometric issues and advances.
They are subject to the same review process as other papers. Reviews are welcomed, but
authors should consult the Editor-in-Chief about the suitability of a proposed Review
before its preparation.
Supplementary Material: Authors are strongly encouraged to provide supplementary
material with their manuscript submissions. This material will be made available for the
reviewing process and will become available to the readers on-line via the Cytometry Part A
website for free once the manuscript is accepted. The intention of supplementary data is to
give additional information to the reviewers and the readers thereby improving the quality
of the manuscript and making it interesting to a broader audience. Supplementary material
is, among others, calibration and standardization procedures, gating strategies for flow and
image cytometry, original unmanipulated images, movies, original data of tables, extensive
methodology, detailed mathematical procedures, working examples of developed software.
Compiled pdf files of Supplementary Materials may be the most accessible format for
readers. This is a suggestion for supplementary file submission, but not a requirement.
Length of Manuscripts and Page Charges
Authors are reminded that brevity is a virtue and contributes to the clarity of their
contribution. Normally, articles will be limited to about 5,000 words and a combined total
of six figures and tables. Authors will be asked to shorten excessively verbose manuscripts.
Authors of articles that exceed eight printed pages will be charged $150 per excess page.
Prior to publication, the Editor-in-Chief may waive this charge for authors who specifically
request exemption and who provide appropriate reasons to justify their request. Color
charges: All color figures will be reproduced in full color in the online edition of the journal
at no cost to authors. Authors are requested to pay a charge of $500 per page to reproduce
color figures in print. Please contact the editor, Larry Graup (firstname.lastname@example.org) for
Reprints are supplied at a cost based on the number of pages in the printed article and
the number of reprints ordered, as shown on the order blank mailed with the proofs. John
Wiley & Sons, Inc. is pleased to extend a 50% discount on all reprint orders placed by ISAC
Submission of a manuscript implies that it has been approved by all named authors, that
it reports unpublished work, and that it is not under consideration for publication
elsewhere. If the manuscript is accepted for publication, it will become the sole property
of the International Society for Advancement of Cytometry and will be copyrighted in the
name of the International Society for Advancement of Cytometry. The manuscript, in
whole or part, must not be published elsewhere in either English or another language.
The views expressed herein are those of the individual authors and are not necessarily
those of the Society or the Publisher. Information included herein is not professional
advice and is not intended to replace the judgment of a practitioner with respect to
particular patients, procedures, or practices. To the extent permissible under applicable
laws, the Publisher and the Society disclaim responsibility for any injury and/or damage to
persons or property as a result of any actual or alleged libelous statements, infringement of
intellectual property or other proprietary or privacy rights, or from use or operation of any
ideas, instructions, procedures, products or methods contained in the materials therein.
Publication of an advertisement does not constitute on the part of the Publisher or the
Society a guaranty or endorsement of the quality or value of the advertised products or
services or of any of the repre-sentations or the claims made by the advertisers.
Requests for copies of the Editorial Policy and Instructions to Contributors, requests for
clarification of specific issues, and all other communications with the Editorial Office
should be addressed to:
Department of Therapy Validation
Fraunhofer Institute for Cell Therapy and Immunology IZI
04103 Leipzig, Germany
E-mail: email@example.com or
Editorial Receiving Office: firstname.lastname@example.org
Telephone (in U.S.): 201-748-7805
Authors may also contact the Associate Editor associated with their region if they have
specific questions regarding whether or not their manuscript may be suitable for
Cytometry Part A.
Revised January 2017